These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20843201)

  • 1. Nanobodies®: proficient tools in diagnostics.
    Huang L; Muyldermans S; Saerens D
    Expert Rev Mol Diagn; 2010 Sep; 10(6):777-85. PubMed ID: 20843201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of nanobodies for therapeutic applications.
    Van Bockstaele F; Holz JB; Revets H
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies in therapeutic applications.
    Roovers RC; van Dongen GA; van Bergen en Henegouwen PM
    Curr Opin Mol Ther; 2007 Aug; 9(4):327-35. PubMed ID: 17694445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablynx makes nanobodies from llama bodies.
    Wolfson W
    Chem Biol; 2006 Dec; 13(12):1243-4. PubMed ID: 17185218
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobodies®: new ammunition to battle viruses.
    Vanlandschoot P; Stortelers C; Beirnaert E; Ibañez LI; Schepens B; Depla E; Saelens X
    Antiviral Res; 2011 Dec; 92(3):389-407. PubMed ID: 21939690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of anti-infectome/anti-proteome nanobodies.
    Hassanzadeh-Ghassabeh G; Saerens D; Muyldermans S
    Methods Mol Biol; 2011; 790():239-59. PubMed ID: 21948420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity anti-Internalin B VHH antibody fragments isolated from naturally and artificially immunized repertoires.
    Gene RW; Kumaran J; Aroche C; van Faassen H; Hall JC; MacKenzie CR; Arbabi-Ghahroudi M
    J Immunol Methods; 2015 Jan; 416():29-39. PubMed ID: 25450000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimerisation strategies for shark IgNAR single domain antibody fragments.
    Simmons DP; Abregu FA; Krishnan UV; Proll DF; Streltsov VA; Doughty L; Hattarki MK; Nuttall SD
    J Immunol Methods; 2006 Aug; 315(1-2):171-84. PubMed ID: 16962608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
    Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
    Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological applications of single-domain llama recombinant antibodies isolated from a naïve library.
    Monegal A; Ami D; Martinelli C; Huang H; Aliprandi M; Capasso P; Francavilla C; Ossolengo G; de Marco A
    Protein Eng Des Sel; 2009 Apr; 22(4):273-80. PubMed ID: 19196718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential tumor-targeting abilities of three single-domain antibody formats.
    Bell A; Wang ZJ; Arbabi-Ghahroudi M; Chang TA; Durocher Y; Trojahn U; Baardsnes J; Jaramillo ML; Li S; Baral TN; O'Connor-McCourt M; Mackenzie R; Zhang J
    Cancer Lett; 2010 Mar; 289(1):81-90. PubMed ID: 19716651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobodies as molecular imaging probes.
    Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
    Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris.
    Ryckaert S; Pardon E; Steyaert J; Callewaert N
    J Biotechnol; 2010 Jan; 145(2):93-8. PubMed ID: 19861136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiological role of llama heavy-chain antibodies against a bacterial beta-lactamase.
    Ferrari A; Rodríguez MM; Power P; Weill FS; De Simone EA; Gutkind G; Leoni J
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):173-82. PubMed ID: 17448545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
    Ji F; Ren J; Vincke C; Jia L; Muyldermans S
    Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.